Suchergebnisse - "Guido Vanham"

PubPharm (24)

1

Efficient Induction of Antigen-Specific CD8

in: Pharmaceutics | 2022

von Sigrid D’haese | Thessa Laeremans | Sabine den Roover | +3

2

Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation

in: Frontiers in Immunology | 2021

von Philipp Adams | Philipp Adams | Philipp Adams | +7

3

Closing schools for SARS-CoV-2: a pragmatic rapid recommendation

in: BMJ Paediatrics Open | 2021

von Bert Aertgeerts | Patrik Vankrunkelsven | Guido Vanham | +19

4

Does Trypsin Oral Spray (Viruprotect

in: International Journal of Environmental Research and Public Health | 2021

von Suzy Huijghebaert | Guido Vanham | Myriam Van Winckel | +1

5

CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice

in: iScience | 2021

von Philipp Adams | Virginie Fievez | Rafaëla Schober | +10

6

A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa

in: International Journal of Infectious Diseases | 2020

von Robert Colebunders | Joseph Nelson Siewe Fodjo | Guido Vanham | +1

7

Correction for global health and revenue effects of increased taxation of tobacco, Alcohol, and Sugar-Sweetened Beverages

in: BMJ Global Health | 2020

von Peter Aaby | Kristien Verdonck | Sameh Al-Awlaqi | +21

8

The COVID-19 pandemic: diverse contexts; different epidemics—how and why?

in: BMJ Global Health | 2020

von Peter Aaby | Kristien Verdonck | Sameh Al-Awlaqi | +21

9

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

in: Trials | 2019

von Wesley de Jong | Joeri Aerts | Sabine Allard | +12

10

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

in: Trials | 2019

von Wesley de Jong | Joeri Aerts | Sabine Allard | +12